Drug Profile
MK 49
Alternative Names: MK-49Latest Information Update: 21 Jan 2016
Price :
$50
*
At a glance
- Originator MIKA Pharma GmbH
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Pain
Most Recent Events
- 20 Jan 2016 Investigation in Pain in Germany (Buccal)
- 20 Jan 2016 Investigation in Pain in Germany (Transmucosal)